Pulse - Ezetimibe reduces vascular events
Links shared publicly online about this topic.
- 692total visits
Pulse - Ezetimibe reduces vascular events
View full resource at pulsetoday.co.uk
Tags: Cholesterol Medication, Zetia, Event
Most Recently Shared on November 29, 2010 at 10:17 am By:
Ezetimibe reduces vascular events: A new investigational study appears to have shown for the first time that pre... http://bit.ly/eC68dI
Merck's Blood Thinner Shows Reduced Heart Events, But Increased Bleeding
rttnews.com — “Drugmaker Merck & Co. (MRK) Saturday said its experimental blood thinner vorapaxar in combination with standard of care was seen to significantly reduce cardio vascular events in heart patients, but saw an increase in bleeding especially in those who have had a stroke.” View full resource at rttnews.com
Most Recently Shared on March 25, 2012 at 5:05 am By:
Merck's Blood Thinner Shows Reduced Heart Events, But Increased Bleeding - RTT News http://t.co/yedpZo95 #health
Novel Antiplatelet Agent Reduces CV Events But Increases Bleeding - Forbes
forbes.com — “Vorapaxar, the novel antiplatelet agent from Merck, appears to effectively reduce cardiovascular death and ischemic events in patients with MI, ischemic stroke, or peripheral vascular disease, but its potential utility is clouded by bleeding complications, including intracranial hemorrhage. Results from the TRA 2P-TIMI 50 (Thrombin Receptor Antagonist in Secondary Prevention of [...]” View full resource at forbes.com
Most Recently Shared on March 24, 2012 at 2:07 pm By:
Novel Antiplatelet Agent Reduces CV Events But Increases Bleeding: Vorapaxar, the novel antiplatelet agent... http://t.co/UiSxUrWH #drug
Meta-Analysis Adds New Evidence For Cancer Benefits Of Daily Aspirin - Forbes
forbes.com — “Although daily aspirin was originally proposed to reduce cardiovascular events, the effects on cancer of daily aspirin have become increasingly apparent while the vascular benefits, especially in primary prevention, have become less clear. Now a new meta-analysis in the Lancet adds significantly new details to our understanding about the effects [...]” View full resource at forbes.com
Most Recently Shared on March 21, 2012 at 12:58 am By:
Meta-Analysis Adds New Evidence For Cancer Benefits Of Daily Aspirin: Although daily aspirin was originally prop... http://t.co/0WlrQvCO
Meta-Analysis Adds New Evidence For Cancer Benefits Of Daily Aspirin - Forbes
forbes.com — “Although daily aspirin was originally proposed to reduce cardiovascular events, the effects on cancer of daily aspirin have become increasingly apparent while the vascular benefits, especially in primary prevention, have become less clear. Now a new meta-analysis in the Lancet adds significantly new details to our understanding about the effects [...]” View full resource at forbes.com
Most Recently Shared on March 20, 2012 at 11:02 pm By:
Meta-Analysis Adds New Evidence For Cancer Benefits Of Daily Aspirin - Forbes http://t.co/57npZlPn
Full coverage of post-MI drugs reduced vascular event rates, out-of-pocket costs
endocrinetoday.com — “AHA Scientific Sessions 2011 ORLANDO, Fla. — Eliminating co-payments for post-MI secondary prevention drugs improved adherence, reduced rates” View full resource at endocrinetoday.com
Most Recently Shared on November 17, 2011 at 4:31 pm By:
Full coverage of post-MI drugs reduced vascular event rates, out-of-pocket costs #AHA11 http://t.co/5rURDLne
Eliminating Co-Payments For Heart Attack Medications Increases Adherence And Reduces Major Vascular Events
medicalnewstoday.com — “The use of specific medications following a heart attack has been shown to reduce cardiovascular events and mortality, however; while highly effective, the rate of adherence to these medications i” View full resource at medicalnewstoday.com
Most Recently Shared on November 16, 2011 at 9:07 am By:
Eliminating Co-Payments For Heart Attack Medications Increases Adherence And Reduces Major Vascular Events http://t.co/hIG1cNov
Hospital Team Significantly Reduced Risk Of Further Vascular Events After 'Mini Strokes'
medicalnewstoday.com — “Patients who had a transient ischaemic attack (TIA), sometimes referred to as a mini stroke, were much less likely to experience further vascular events in the first year if their care was co-or” View full resource at medicalnewstoday.com
Most Recently Shared on October 28, 2011 at 9:05 am By:
Hospital Team Significantly Reduced Risk Of Further Vascular Events After 'Mini Strokes' http://t.co/xgas9aE2 #vascular
Special team care reduces cumulated stroke risk after transient ischaemic attacks
news-medical.net — “Patients who had a transient ischaemic attack (TIA), sometimes referred to as a "mini stroke", were much less likely to experience further vascular events in the first year if their care was co-ordinated by a special hospital team. That is the key finding from a study published in the November issue of the European Journal of Neurology.” View full resource at news-medical.net
Most Recently Shared on October 28, 2011 at 6:10 am By:
Stroke News: Special team care reduces cumulated stroke risk after transient ischaemic attacks: Patients who had... http://t.co/M5nimHf2
Reducing Vascular Events Risk in Patients With Dyslipidaemia - QualityPoint Technologies
qualitypointtech.net — “The authors present methods of risk assessment for cardiovascular events in patients with dyslipidemia, as well as guidelines for risk reduction. Therapeutic Advances in Chronic Disease” View full resource at qualitypointtech.net
Most Recently Shared on October 7, 2011 at 10:45 am By:
Reducing Vascular Events Risk in Patients With Dyslipidaemia: The authors present methods of risk assessment for c... http://t.co/p9gTefWo
Reduce Your Heart Disease Risk with a Free Event in September « Heart & Vascular
advancingyourhealth.org — “Reduce Your Heart Disease Risk with a Free Event in September « Heart & Vascular” View full resource at advancingyourhealth.org
Most Recently Shared on September 5, 2011 at 5:10 pm By:
RT @emoryhealthsci All September @EmoryHealthcare - Reduce your #heart disease risk through free lecture series: http://ow.ly/6hMEi #atlanta
Reduce Your Heart Disease Risk with a Free Event in September « Heart & Vascular
advancingyourhealth.org — “Reduce Your Heart Disease Risk with a Free Event in September « Heart & Vascular” View full resource at advancingyourhealth.org
Most Recently Shared on August 31, 2011 at 6:40 pm By:
Four easy opportunities in to reduce your risk for heart disease: http://t.co/hwLxSb1 #events #atlanta
Statins may reduce risk of recurrent vascular events in young stroke patients - - ModernMedicine
modernmedicine.com — “Young adults treated with a statin after a first ischemic stroke of undetermined cause were 77% less likely to suffer subsequent vascular events, according to a recent study published in Neurology.” View full resource at modernmedicine.com
Most Recently Shared on August 17, 2011 at 9:09 pm By:
Stroke News: Statins may reduce risk of recurrent vascular events in young stroke patients -... http://t.co/LeANuFI ChicagoEndovascular
MedWire News - Stroke - Statins advised for young adults with stroke of unknown cause
medwire-news.md — “MedWire News Prescribing statins to young stroke survivors may reduce their risk for subsequent vascular events, even if the stroke etiology is unclear, researchers report in the journal Neurology. MedWire News” View full resource at medwire-news.md
Most Recently Shared on August 3, 2011 at 8:49 pm By:
Statins advised for young adults with stroke of unknown cause: Prescribing statins to young stroke survivors may... http://bit.ly/qYacrM
6 Opportunities to Reduce Your Heart Disease Risk in August « Heart & Vascular
advancingyourhealth.org — “6 Opportunities to Reduce Your Heart Disease Risk in August « Heart & Vascular” View full resource at advancingyourhealth.org
Most Recently Shared on August 2, 2011 at 3:02 pm By:
Happy Tuesday! We're kicking off the day w/ 6 opportunities to reduce your risk for heart disease in August! http://bit.ly/HeartWiseAug
WARFARIN Study initiated to assess utility of genetic testing to reduce warfarin-related adverse events
news-medical.net — “Iverson Genetic Diagnostics, Inc. announced that the WARFARIN Study was initiated at Colorado Heart & Vascular, P.C. in Denver and other major hospital systems nationwide to assess the utility of genetic testing to determine a personalized warfarin dose for individual patients to reduce their risk of serious bleeding or clotting events.” View full resource at news-medical.net
Most Recently Shared on July 30, 2011 at 8:54 am By:
Medicare News: WARFARIN Study initiated to assess utility of genetic testing to reduce warfarin-related adverse ... http://bit.ly/r42Vqd
Advertisement

